Access provided by
London Metropolitan University
This article explores the use of the atypical antipsychotic drug, risperidone. It will identify its core features and chemical properties and compare it with other commonly available interventions in its use with people with autism spectrum conditions (ASC). Common and rarer side effects of risperidone are explored. The discontinuation trials of two students with ASC are examined. Data were collected on the students’ daily arousal levels to monitor any changes following discontinuation. The results showed a significant increase in the time student A spent at optimum arousal, while student B showed a clear movement away from his optimum arousal level and into a state of higher arousal. The different outcomes suggest that risperidone may have beneficial effects for some people but not for others. The use of antipsychotic medication may have short-term benefits but must be reviewed regularly and appropriate behavioural intervention programmes should always be considered as an alternative treatment to pharmacological interventions.
Learning Disability Practice. 20, 6, 29-35. doi: 10.7748/ldp.2017.e1854
Correspondence Peer reviewThis article has been subject to external double-blind peer review and checked for plagiarism using automated software
Conflict of interestNone declared
Write for usFor information about writing for RCNi journals, contact writeforus@rcni.com
For author guidelines, go to rcni.com/writeforus
Received: 21 March 2017
Accepted: 18 July 2017
Alternatively, you can purchase access to this article for the next seven days. Buy now
Are you a student? Our student subscription has content especially for you.
Find out more